In the Journals

Study shows population estimates of melanocytic lesions

November 27, 2017
A diagnosis of melanocytic proliferation was reported in almost 25% of skin biopsies, according to results of a large population-based study. …

In the Journals

Topical patidegib granted FDA breakthrough, orphan statuses for Gorlin syndrome

November 21, 2017
The FDA has granted breakthrough therapy designation and orphan drug designation to topical patidegib for the treatment of basal cell carcinoma nevus…

In the Journals

Squamous cell carcinoma associated with increased mortality

November 20, 2017
Squamous cell carcinoma was associated with a 25% increase in all-cause mortality compared with patients in the general population. Investigators of…

In the Journals

T-VEC, ipilimumab regimen improves survival in advanced melanoma

November 10, 2017
The combination of an oncolytic virus plus a checkpoint inhibitor improved survival among patients with advanced melanoma compared with monotherapy…

In the Journals

Immunosuppression in multiple myeloma may not increase melanoma risk

November 3, 2017
Although immunosuppression associated with multiple myeloma may not predispose patients to melanoma, other immunosuppressed states may increase…

In the Journals

Education increased sunscreen use among student athletes

October 26, 2017
An educational intervention targeting sunscreen use in student athletes was associated with improved sunscreen use. Researchers with the Stanford…

IL-12 therapy elicits encouraging response rates in melanoma

October 25, 2017
Immunopulse IL-12 monotherapy and in combination with pembrolizumab was associated with encouraging response rates and safety data in patients with…

In the Journals

Radial video mosaicing may aid in mapping lentigo maligna

October 23, 2017
Handheld reflectance confocal microscopy with radial video mosaicing showed utility in mapping lentigo maligna and lentigo maligna melanoma. The…

FDA News

FDA grants breakthrough therapy designation to Tafinlar-Mekinist combination for adjuvant treatment of BRAF-positive melanoma

October 23, 2017
The FDA granted breakthrough therapy designation to the combination of dabrafenib and trametinib for adjuvant therapy of patients with stage III…

In the Journals

Post-transplant squamous cell carcinoma incidence declined in recent years

October 20, 2017
There has been a consistent decline in squamous cell carcinoma post-transplant among organ transplant recipients in Norway since the 1980s, according…

In the Journals

One in five young women dependent on indoor tanning

October 19, 2017
Data from a recent survey demonstrate indoor tanning dependence was linked with symptoms of depression and beliefs about physical appearance. The…

FDA News

FDA grants priority review to Opdivo for resected, high-risk melanoma

October 17, 2017
The FDA granted priority review to nivolumab for the treatment of patients with melanoma who are at high risk for disease recurrence following…

Meeting News

Residual atypical intraepidermal melanocytic proliferation may predict melanoma diagnosis

October 12, 2017
Increasing proportions of atypical intraepidermal melanocytic proliferation on various parts of the body may increase the likelihood of a diagnostic…

Meeting News

Upgrade to more aggressive subtype common in Mohs surgery patients

October 11, 2017
Patients undergoing Mohs micrographic surgery for aggressive subtypes of nonmelanoma skin cancer were frequently upgraded to a more aggressive…

USPSTF: Evidence lacking to determine benefits, harms of skin cancer self-exams

October 10, 2017
In a draft recommendation statement, the U.S. Preventive Services Task Force said there is insufficient evidence to determine if the benefits…

In the Journals

Experts recommend reviewing prior authorization policy for skin biopsies

October 10, 2017
Research is needed to address the utility and impact of prior authorization for skin biopsies, according to three authors of a recent opinion paper…

In the Journals

Medicaid patients experience longest delays in melanoma surgery

October 4, 2017
Patients with melanoma were more likely to experience delays in surgery if they were insured by Medicaid compared with Medicare or private insurance…

In the Journals

Pembrolizumab superior to ipilimumab in advanced melanoma

October 3, 2017

Video

Baseball Hall of Famer Mike Schmidt promotes sun protection, skin cancer awareness

September 28, 2017
Mike Schmidt, a Major League Baseball Hall of Famer who played 17 seasons with the Philadelphia Phillies, received a stage III melanoma diagnosis in…

Video

Baseball Hall of Famer: Physician’s confidence affects patients

September 26, 2017
Mike Schmidt, whose success during his 17-year career with the Philadelphia Phillies earned him induction into the National Baseball Hall of Fame…

Healio Jobs